AstraZeneca's Voydeya gets US FDA approval as add-on therapy to ravulizumab or eculizumab to treat EVH in adults with the rare disease PNH
In: PharmaBiz, 2024-04-02
serialPeriodical
Zugriff:
Voydeya (danicopan) has been approved in the US as add-on therapy to ravulizumab or eculizumab for the treatment of extravascular haemolysis (EVH) in adults with paroxysmal nocturnal haemoglobinuria (PNH). Voydeya [...]
Titel: |
AstraZeneca's Voydeya gets US FDA approval as add-on therapy to ravulizumab or eculizumab to treat EVH in adults with the rare disease PNH
|
---|---|
Zeitschrift: | PharmaBiz, 2024-04-02 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|